Home/PureTech Health/Sharon Barber-Lui
SB

Sharon Barber-Lui

Interim Chair of the Board of Directors, Audit Committee Member

PureTech Health

PureTech Health Pipeline

DrugIndicationPhase
LYT-100 (Deupirfenidone)Idiopathic Pulmonary Fibrosis (IPF)Phase 2b
LYT-200Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Solid TumorsPhase 1/2
LYT-300Neuropsychiatric ConditionsPhase 2
LYT-310UndisclosedPreclinical
Glyph Platform CandidatesNon-opioid PainPreclinical
Cobenfy™ (KarXT)Schizophrenia in AdultsApproved
EndeavorRx®Pediatric ADHDApproved
Plenity®Weight ManagementApproved